Table 1.
Laboratory Findings.
| <CBC> | <Urinalysis> | |||||
| White blood cells | 5,900 | /µL | pH | 5.5 | ||
| Neutrophil | 77 | % | Protein | 1+ | ||
| Eosinophil | 3.0 | % | Glucose | 1+ | ||
| Monocyte | 7.0 | % | Occult blood | ± | ||
| Lymphocyte | 10 | % | Sediment | negative | ||
| Red blood cells | 403×104 | /µL | ||||
| Hemoglobin | 12.7 | g/dL | <Biochemistry> | |||
| Platelet | 31.9×104 | /µL | Total protein | 7.0 | g/dL | |
| Albumin | 2.4 | g/dL | ||||
| <Serology> | Total bilirubin | 0.4 | g/dL | |||
| C-reactive protein | 0.14 | mg/dL | Aspartate aminotransferase | 27 | U/L | |
| Erythrocyte sedimentation rate | 59 | mm/h | Alanine aminotransferase | 21 | U/L | |
| Rheumatoid factor (qualitative test) | negative | Lactate dehydrogenase | 194 | U/L | ||
| Anti-citrullinated protein antibody | 2.4 | U/mL | Alkaline phosphatase | 252 | U/L | |
| IgG | 2,807 | mg/dL | Creatinine kinase | 96 | U/L | |
| IgG4 | 233 | mg/dL | Blood urea nitrogen | 21 | mg/dL | |
| IgA | 369 | mg/dL | Creatinine | 1.22 | mg/dL | |
| IgM | 79 | mg/dL | Ferritin | 136 | ng/mL | |
| IgE | 5,507 | IU/mL | Iron | 45 | µg/dL | |
| C3 | 78 | mg/dL | Sialylated carbohydrate antigen (KL-6) | 719 | U/mL | |
| C4 | 40 | mg/dL | ||||
| CH50 | 58.0 | U/mL | ||||
| Antinuclear antibody | ×40 | |||||
| (Speckled pattern) | ||||||
| SS-A | <1.0 | U/mL | ||||
| SS-B | <1.0 | U/mL | ||||
| sIL-2R | 961 | U/mL | ||||
| <Interferon-gamma release test (T-SPOT)> | negative | |||||
| <Tumor marker> | ||||||
| CEA | 2.4 | ng/mL | ||||
| CA19-9 | 5.1 | U/mL | ||||
| SCC | 18.3 | ng/mL | ||||
| CYFRA | 3.9 | ng/mL | ||||
| proGRP | 44.0 | pg/mL | ||||
| NSE | 13.2 | ng/mL | ||||
CA19-9: carbohydrate antigen 19-9, CEA: carcinoembryonic antigen, proGRP: pro-gastrin-releasing peptide, NSE: neuron specific enolase, SCC: squamous cell carcinoma antigen, sIL-2R: soluble interleukin-2 receptor